ACJK, Inc. v. OptumRX, Inc.

United States Bankruptcy Court, S.D. Illinois·Decided June 10, 2026·No. 25-03011·Unknown

Opinion

UNITED STATES BANKRUPTCY COURT

SOUTHERN DISTRICT OF ILLINOIS

In Re ) ) Case No. 23-30045 ACJK, Inc., ) ) Chapter 11 Debtor. ) ) ACJK, Inc., ) ) Plaintiff, ) v. ) Adv. No. 25-03011 ) OptumRX, Inc., ) ) Defendant. ) ___________________________________ ) ) In Re ) ) Case No. 23-30045 ACJK, Inc., ) ) Chapter 11 Debtor. ) ) ACJK, Inc. ) ) Plaintiff, ) v. ) Adv. No. 25-03012 ) Express Scripts, Inc., ) ) Defendant. )

O P I N I O N

Before the Court are motions to dismiss filed by the defendants in two separate adversary proceedings commenced by the debtor in the same underlying bankruptcy case. The motions seek dismissal of the claims against the defendants pursuant to Federal Rule of Civil Procedure 12(b)(6) for failure to state a claim. For the reasons set forth herein, the motions to dismiss will be granted in part and denied in part.

I. Factual Background ACJK, Inc. (“Debtor”), a corporation that operated a pharmacy in Granite City, Illinois, commenced its voluntary Chapter 11 case on January 30, 2023, by filing a bare-bones petition. The Debtor’s schedules and other required documents were filed a month later. On Schedule D: Creditors Who Have Claims Secured by Property, the Debtor listed Express Scripts, Inc., OptumRX, Inc., and others as holders of claims in unknown amounts secured by the pharmacy’s accounts receivable valued at $228,800. The debts were marked by the Debtor

as being “disputed.” Among the assets listed on Schedule A/B, the Debtor identified potential causes of action for breach of contract and misrepresentation against OptumRX, Express Scripts, and others of unknown values. On its Statement of Financial Affairs, the Debtor identified OptumRX and Express Scripts as recipients of prepetition transfers in unknown amounts described as “offset DIR fees from Debtor’s accounts receivable.” OptumRX and Express Scripts were similarly identified as having set off debts owed to them by taking unknown amounts from the Debtor’s financial account without permission.

Neither entity filed a proof of claim in the case. But several other creditors filed claims, including on account of unsecured prepetition debts. The Debtor’s Second Amended Chapter 11 Plan was confirmed on March 5, 2024. The plan defined “DIR Fees” as “pharmaceutical-related expenses deducted from Debtor’s gross sale proceeds by Pharmacy Benefit Mangers [sic] (PBM’s) [sic], including” OptumRX and Express Scripts. The plan was to be implemented in part through a litigation fund comprised of proceeds that might

be obtained in pursuing prepetition causes of action for the benefit of creditors against the PBMs in relation to DIR Fees collected. On January 29, 2025, the Debtor commenced an adversary proceeding against OptumRX, Express Scripts, and several other entities asserting causes of action against each for unauthorized postpetition transfers and constructively fraudulent prepetition transfers under federal and state law based on DIR Fees deducted from the Debtor’s accounts receivable in the months and years surrounding the petition date.1 In an order entered February 13, 2025, the Judge

previously assigned to the proceeding found that, among other deficiencies, the complaint impermissibly joined defendants in the same cause of action for what appeared to be separate and distinct transactions or occurrences and directed the Debtor to file separate adversary complaints against each defendant within 21 days. After an initial motion to reconsider was denied, the Debtor filed another document labeled as a motion to reconsider or for clarification, asserting that it had a right to file an amended complaint as a matter of course through which it hoped to cure any issues. Consistent with that position, the Debtor filed a first

amended complaint which asserted essentially the same causes of action against the same defendants. Several named defendants objected and asked the Court

1 The complaint identified OptumRX as “United Health Group d/b/a OptumRX, Inc. f/k/a Catamaran, Inc.” The Motion to Dismiss in adversary case no. 25-03011 was filed on behalf of OptumRX. to strike the amended complaint. Rather than strike the amended complaint, at a hearing held on May 22, 2025, the Court ordered that the claims be severed so that there would be separate adversary proceedings against each defendant and

further ordered the Debtor’s attorney to pay the filing fee for each of the severed cases. The filing fees were paid, and the result was separate proceedings against each defendant all based on the same first amended complaint. Relevant to the present proceedings, Count I of the first amended complaint alleges that OptumRX and Express Scripts deducted DIR Fees in unknown amounts from the Debtor’s accounts receivable after the petition date of January 30, 2023. Because the Debtor ceased operations on January 21, 2023, the Debtor alleges that such deductions must have been on account of

prepetition claims and are therefore avoidable under §549(a). Count I further seeks an accounting and recovery of amounts avoided under §§542(a) and 550(a). Counts VI and VII seek to avoid constructively fraudulent transfers to Express Scripts under §548(a)(1)(B) and 740 ILCS 160/5, respectively. Count VI alleges that, between January 31, 2021, and January 30, 2023, Express Scripts “offset approximately $103,142.84 in DIR FEEs from [the Debtor’s] Accounts Receivable” for obligations incurred by the Debtor within that period. The Debtor

alleges that it received less than a reasonably equivalent value in exchange for the “excessive” DIR Fees collected and that it was insolvent at the time or made insolvent thereby. Count VI further alleges that Express Scripts was an insider of the Debtor as defined in the Bankruptcy Code. Count VII, in turn, alleges that Express Scripts “offset approximately $136,362.47 in DIR FEES from [the Debtor’s] Accounts Receivable” between January 31, 2019, and January 30, 2023, on account of obligations incurred by the Debtor over the same period.

The Debtor alleges it received less than a reasonably equivalent value for the described transfers and that the Debtor was “insolvent on the date the [allegedly fraudulent] transfers were made and/or incurred or became insolvent as a result of such transfers.” Counts XII and XIII similarly seek to avoid constructively fraudulent transfers to OptumRX under §548(a)(1)(B) and 740 ILCS 160/5, respectively. They make the same allegations against OptumRX that are set forth in Counts VI and VII against Express Scripts, differing only in the amounts of the alleged

transfers. In that regard, Count XII alleges that OptumRX “offset approximately $196,692.18 in DIR FEEs” in the two-year period ending on the petition date, and Count XIII alleges that OptumRX “offset approximately $332,570.05 in DIR FEES” in the four years preceding the bankruptcy. Although OptumRX and Express Scripts are represented by different attorneys, each filed substantially identical Motions to Dismiss ACJK, Inc.’s First Amended Complaint Pursuant to Federal Rule of Civil Procedure 12(b)(6) for Failure to State a Claim and related supporting briefs (collectively “Motions to

Dismiss”) in the respective proceeding against them. On September 25, 2025, the above-captioned proceedings, along with the other severed actions based on the same amended complaint, were reassigned to the undersigned Judge. A hearing was set for status on pending matters in each proceeding.

Free access — add to your briefcase to read the full text and ask questions with AI

ACJK, Inc. v. OptumRX, Inc., (Ill. 2026).

ACJK, Inc. v. OptumRX, Inc. (ACJK, Inc. v. OptumRX, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Stern v. Marshall
131 S. Ct. 2594 (Supreme Court, 2011)
Browning v. Levy
283 F.3d 761 (Sixth Circuit, 2002)
George McReynolds v. Merrill Lynch
694 F.3d 873 (Seventh Circuit, 2012)
Bissessur v. Indiana University Board of Trustees
581 F.3d 599 (Seventh Circuit, 2009)
Kmart Corp. v. Intercraft Co. (In Re Kmart Corp.)
310 B.R. 107 (N.D. Illinois, 2004)